← Back to all trials
Recruiting
NCT04802395
Real World Evidence Clinical Utility Study of KidneyIntelX
Conditions: Chronic Kidney Diseases, Diabetic Kidney Disease
Sex: All
Ages: 23 Years – N/A
Healthy volunteers: No
Enrollment: 10000
Sponsor: Renalytix AI, Inc.
Location: Mount Sinai Health System New York New York
Summary
The purpose of this study is to assess the impact of the KidneyIntelX assay utilized as part of the current standard of care on the management of patients seen in the primary care physician's office at Mount Sinai.
Eligibility Criteria
Inclusion Criteria:
* Individuals with Type 2 diabetes and concurrent chronic (diabetic) kidney disease (G3a-G3b or G1-G2, A2-A3) per KDIGO CKD staging.
Exclusion Criteria:
* Patents without the appropriate characteristics as identified in the KidneyIntelX intended use population.
* Patients with eGFR \
Source: ClinicalTrials.gov (NCT04802395). StuddyBuddy aggregates publicly available trial information.
